All In MedTech

Company

Retractable Technologies

Funding, FDA decisions, device trials, adverse event reports and recalls filed under this company's name in public data. Records are matched by name, so a subsidiary or an unusual spelling can be missed.

Last checked: Nov 19, 2026Source: SEC EDGAR, openFDA and ClinicalTrials.govMethods & limitations

This company is not on our public-company list, so only this exact name is matched. Naming a company here is not a recommendation of it or of any security.

Financing

Public company. Figures from its SEC financial statements.

Public

Listed

RVP

NYSE · RETRACTABLE TECHNOLOGIES INC

Public float

$8.1M

Value of shares held by non-insiders on Jun 30, 2025

Revenue

$38.3M

Fiscal year ending Dec 31, 2025

Net income

-$12.6M

Fiscal year ending Dec 31, 2025

R&D spending

$676K

Fiscal year ending Dec 31, 2025

Cash

$1.9M

As of Sep 30, 2026

Long-term debt

$896K

As of Dec 31, 2025

Shares outstanding

29.9M

As of Nov 1, 2026

Capital raised as a public company

Cash received from selling stock and borrowing, from each year's cash-flow statement in the annual report. Fiscal years, by the year each one ended.

YearIPOStock soldLong-term debtConvertible debt
2021–$5.3M––

Not in public filings: valuations, share prices and investors' names. Private databases such as PitchBook and Crunchbase estimate these from press releases and surveys. Not every round is filed: companies raising under other exemptions, or from foreign investors only, may not file Form D. Nothing here is investment advice.

Investors

5%+ shareholders from SEC Schedule 13D/13G filings since Dec 1, 2024, and SBIR/STTR grants (NIH through Nov 10, 2026, other agencies through 2023). Venture investors in private rounds are not in public filings.

No 5%+ shareholder filings or SBIR grants found under the name Retractable Technologies.

Latest FDA decisions

Search the Clearance Tracker

Device trials

Trials on ClinicalTrials.gov that list this company as lead sponsor, most recently updated first.

Open in the Trial Radar

No device trials list this company as lead sponsor.

Reports received

24

Received Nov 1, 2025 to Nov 20, 2026. Includes 1 of another or unstated type.

Malfunction reports

22

92% of reports

Injury reports

1

4.2% of reports

Death reports

0

0.0% of reports

Adverse event reports received per month

Reports that name this company as manufacturer, by the date FDA received them. The newest month is incomplete.

Search the MAUDE Monitor
  • Malfunction
  • Injury
  • Death
  • Other
View as table
MonthMalfunctionInjuryDeathOther
Dec 231000
Jan 244100
Feb 241000
Mar 247000
Apr 241000
May 243100
Jun 243000
Jul 242000
Aug 241000
Sep 244000
Oct 241000
Nov 243000
Dec 243000
Jan 251100
Feb 250000
Mar 253000
Apr 252000
May 251000
Jun 253000
Jul 251000
Aug 254000
Sep 250000
Oct 252000
Nov 251000
Dec 251000
Jan 267000
Feb 260000
Mar 263100
Apr 261000
May 260000
Jun 261000
Jul 262000
Aug 261001
Sep 262000
Oct 263000
Nov 260000

Device types named most often

Last 12 months, by FDA product code. A company that sells more gets more reports.

Brand names named most often

Last 12 months, as written on the reports. One product can appear under several spellings.

7 more in this ranking with a free account

Recent recalls

From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.

Back to all tools

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.